From Virtual Molecules to Clinical Trials: How AI Is Reshaping Preclinical Drug Discovery
Journal of Medical Internet Research · 29.05.2026 · 28 · e101366-e101366
DOI: 10.2196/101366 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Internet Research, online erschienen am 29.05.2026. Verfasst von Benedette Cuffari. Hauptthemen laut MEDLINE: Artificial Intelligence, Clinical Trials as Topic, Drug Discovery. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Pharmaceutical development is typically a long and arduous process, but advances in artificial intelligence may help streamline each stage of this pipeline. In this News and Perspectives article, JMIR Correspondent Benedette Cuffari reports on recent innovations and their potential implications for drug discovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Zitieren
APA
Cuffari, B. (2026). From Virtual Molecules to Clinical Trials: How AI Is Reshaping Preclinical Drug Discovery. Journal of Medical Internet Research, 28, e101366-e101366. https://doi.org/10.2196/101366
Vancouver
Cuffari B. From Virtual Molecules to Clinical Trials: How AI Is Reshaping Preclinical Drug Discovery. Journal of Medical Internet Research. 2026;28:e101366-e101366. doi:10.2196/101366
BibTeX
@article{Cuffari2026,
author = {Cuffari, Benedette},
title = {From Virtual Molecules to Clinical Trials: How AI Is Reshaping Preclinical Drug Discovery},
journal = {Journal of Medical Internet Research},
year = {2026},
volume = {28},
pages = {e101366--e101366},
doi = {10.2196/101366}
}
EUVIMED